Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Swedish University President Awarded Prestigious Distinction
Karolinska Institutet accounts for almost half of the academic medical research conducted in Sweden, and contributes regularly to new discoveries that save lives and alleviate suffering. Today, the university"s president, Harriet Wallberg-Henriksson, is to receive an honorary distinction for eminent women in science by Exploratorium, the renowned American science museum.
generic viagra online
Health Lobbying Means Cash Infusion For Candidates, TV StationsKaiser
"Health care groups working feverishly to shape -- or kill -- an industry-wide reform bill are lavishing campaign cash on the politicians at the center of the debate," The Salt Lake (Utah) Tribune reports. Sens. Orrin Hatch and Max Baucus, both major health reform players on the Senate Finance Committee, are among those benefiting form the uptick in contributions. One lobbyist for the watchdog group Public Citizen said, "A person can reach no other conclusion than this is quid pro quo activity" (Canham, 7/27).
News of the day
General Medical Council Announces Launch Date For Doctors' Licences, UK
The GMC has announced the launch date of a milestone in medical regulation. From 16 November, all doctors will need a licence in order to practise medicine in the UK.
Sexual Health

Cook Medical Brings Advanced Endovascular Thoracic Aneurysm Treatment To Canadians

In a move reflecting the rapid acceptance of Cook Medical"s advanced endogaft for thoracic aortic aneurysm worldwide, the company has received approval to market the Zenith TX2® TAA Endovascular Graft in Canada. Globally, the Zenith TX2 Endovascular Graft is now available in more than 60 markets, including the United States, Canada, the United Kingdom, European Union, Australia and others internationally. "Physicians around the world have made Cook"s Zenith AAA Endograft the world"s best-selling device of its kind, and we"re now seeing similar momentum in the growing market for endovascular treatment of thoracic aortic aneurysms," said Phil Nowell, global leader of Cook"s aortic intervention business unit. One of Canada"s leading endovascular specialists, Cherrie Abraham, M.D., Department of Vascular Surgery, Jewish General Hospital at McGill University, Montreal, Quebec, said: "This approval is a recognition that this is an excellent graft that is here to stay. The biggest advantage with TX2 is the control offered by the tri-fold proximal end. With TX2, we now have the ability to deploy a graft without the wind-sock effect that is seen with other commercially approved thoracic stent grafts. I also like that even after unsheathing the graft, you still have the ability to advance it proximally, again because of the constrained top end." U.S. sales of Cook"s TX2 Endograft have increased every month since it received FDA clearance in June 2008. During that period, approximately 1,000 physicians at nearly 400 hospitals in the U.S. have requested and received training in the appropriate use of the TX2, making them eligible to bring the advanced benefits of this device to numerous patients suffering thoracic aortic aneurysms. "With sales of the Zenith TX2 Endograft accelerating each month, and the recent CE Mark approval for our next-generation TX2 Endograft with Pro-Form*, we believe Cook is on track to achieve market leadership in thoracic aneurysms, as well." Just as it is in the United States, the Zenith TX2 Endograft is indicated for the endovascular treatment of patients with aneurysms or ulcers of the descending thoracic aorta having vascular morphology suitable for endovascular repair. * The TX2 Endograft with Pro-Form is not available for sale in the U.S. or Canada. Cook Medical


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009